Latest Breaking News On - Sarah lundberg - Page 1 : comparemela.com

GALWAY, Ireland, November 14, 2023 Vivasure Medical®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced it has enrolled the 100th patient in its PATCH Clinical Study, a multi-center, single-arm, pivotal study evaluating the safety and efficacy of the Vivasure PerQseal® Closure Device System. The U.S. Food and Drug Administration (FDA) granted investigational device exemption (IDE) approval earlier this year to advance the PATCH study forward

United statesVivasure perqsealSarah lundbergDrug administrationPerqseal closure device systemVivasure medicalClosure deviceAndrew glassChief executive officerInvestigational device exemptionClinical studyVivasure medicalBusiness wire